Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021
10/13/2021 - 06:00 AM
GOLETA, Calif. --(BUSINESS WIRE)--
Inogen, Inc INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021 . The Company will host a corresponding conference call beginning at 2:00pm PT /5:00pm ET .
Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/ .
A replay of the call will be available beginning, November 4, 2021 at 4:00pm PT / 7:00pm ET through 4:00pm PT / 7:00pm ET on November 18, 2021 . To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13722625. The webcast will also be available on Inogen's website for one year following the completion of the call.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/ , as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/ .
About Inogen
We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com .
View source version on businesswire.com : https://www.businesswire.com/news/home/20211013005220/en/
Investor Relations & Media Contact:
Ali Bauerlein
ir@inogen.net
Source: Inogen, Inc.
INGN Rankings
#5337 Ranked by Stock Gains
INGN Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Goleta
About INGN
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
